Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.96B | 2.06B | 1.86B | 1.57B | 1.23B | 1.09B |
Gross Profit | 1.23B | 1.29B | 1.01B | 948.00M | 755.00M | 666.73M |
EBITDA | 491.00M | 530.00M | 432.00M | 431.00M | 323.00M | 278.10M |
Net Income | 256.00M | 284.00M | 246.00M | 268.00M | 205.00M | 175.00M |
Balance Sheet | ||||||
Total Assets | 4.71B | 5.10B | 4.93B | 2.34B | 1.99B | 1.43B |
Cash, Cash Equivalents and Short-Term Investments | 420.00M | 434.00M | 594.00M | 441.00M | 311.00M | 371.32M |
Total Debt | 238.00M | 250.00M | 259.00M | 217.00M | 203.00M | 212.69M |
Total Liabilities | 862.00M | 991.00M | 1.27B | 702.00M | 620.00M | 444.40M |
Stockholders Equity | 3.85B | 4.11B | 3.66B | 1.64B | 1.37B | 990.04M |
Cash Flow | ||||||
Free Cash Flow | 188.00M | 244.00M | 258.00M | 271.00M | 297.00M | 218.11M |
Operating Cash Flow | 348.00M | 413.00M | 284.00M | 341.00M | 353.00M | 279.05M |
Investing Cash Flow | -437.00M | -456.00M | 35.00M | -84.00M | -341.00M | -61.32M |
Financing Cash Flow | -158.00M | -156.00M | -142.00M | -133.00M | -82.00M | -22.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | kr11.26B | 50.36 | 25.53% | 8.71% | 20.72% | 122.06% | |
75 Outperform | $23.01B | 74.42 | 5.83% | 3.96% | 6.33% | 291.12% | |
72 Outperform | kr11.46B | 44.74 | 6.41% | 11.13% | -1.01% | 6.10% | |
65 Neutral | $9.13B | 66.68 | 6.57% | ― | 32.98% | 35.77% | |
62 Neutral | $17.64B | 146.93 | 18.01% | ― | 52.17% | -54.60% | |
46 Neutral | C$189.62M | -4.26 | -8.56% | 3.09% | 13.57% | -1.98% |
Biotage AB has re-classified 2,611 class C shares to ordinary shares as part of its long-term incentive plan from 2022. This re-classification has increased the total number of votes in the company by 2,349.9, while the total number of shares remains unchanged, reflecting a strategic move to fulfill commitments to participants in the incentive plan.